Is Palisade Bio Stock a good buy in 2023, according to Wall Street analysts?
The consensus among 2 Wall Street analysts covering (NASDAQ: PALI) stock is to Strong Buy PALI stock.
Out of 2 analysts, 2 (100%) are recommending PALI as a Strong Buy, 0 (0%) are recommending PALI as a Buy, 0 (0%) are recommending PALI as a Hold, 0 (0%) are recommending PALI as a Sell, and 0 (0%) are recommending PALI as a Strong Sell.
What is PALI's forecast return on equity (ROE) for 2023-2023?
(NASDAQ: PALI) forecast ROE is -341.01%, which is considered weak.
What is PALI's Price Target?
According to 2 Wall Street analysts that have issued a 1 year PALI price target, the average PALI price target is $33.00, with the highest PALI stock price forecast at $50.00 and the lowest PALI stock price forecast at $16.00.
On average, Wall Street analysts predict that Palisade Bio's share price could reach $33.00 by May 16, 2024. The average Palisade Bio stock price prediction forecasts a potential upside of 1,962.5% from the current PALI share price of $1.60.
What is PALI's forecast return on assets (ROA) for 2023-2023?
(NASDAQ: PALI) forecast ROA is -307.16%, which is lower than the forecast US Biotechnology industry average of -9.12%.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.